Xeris Pharmaceuticals, Inc.

IL · United States · Reporting entity ID 100000781817

Total reported 2019–2025

$11.6M

#450 of 2,960 reporting companies — 0% of all reported industry payments

$5.32M in general payments across 128,324 records, plus $6.27M in research funding across 263 records.

How it breaks down

General payments $5,317,085

Research funding $6,265,464

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.